Premium
CC‐99282 IS A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT WITH POTENT AND BROAD ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Author(s) -
LopezGirona A,
Groocock L,
Mo Z,
Narla R. K,
Janardhanan P,
Wood S,
Mendy D,
Barnes L,
Peng S,
Jankeel D,
Fontanillo C,
Carrancio S,
Hansen J
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.144_2880
Subject(s) - cancer research , lenalidomide , lymphoma , cereblon , cell culture , venetoclax , biology , microbiology and biotechnology , chemistry , immunology , leukemia , chronic lymphocytic leukemia , multiple myeloma , ubiquitin ligase , gene , biochemistry , genetics , ubiquitin